The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk

Eva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, Sarah Costantino, Carla Bettoni, Thomas Knöpfel, Sibylle Sabrautzki, Bettina Lorenz-Depiereux, Johanne Pastor, Tim M. Strom, Martin Hrabě de Angelis, Giovanni G. Camici, Francesco Paneni, Carsten A. Wagner, Isabel Rubio-Aliaga, “The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk,” Kidney Int. 2018 Jul;94(1):49-59. doi: 10.1016/j.kint.2018.02.017. Epub 2018 May 5.